Endothelial-specific deficiency of megalin in the brain protects mice against high-fat diet challenge.
High-fat diet
Leptin
Megalin
Mitochondrial biogenesis
Obesity
Journal
Journal of neuroinflammation
ISSN: 1742-2094
Titre abrégé: J Neuroinflammation
Pays: England
ID NLM: 101222974
Informations de publication
Date de publication:
14 Jan 2020
14 Jan 2020
Historique:
received:
13
09
2019
accepted:
06
01
2020
entrez:
16
1
2020
pubmed:
16
1
2020
medline:
18
11
2020
Statut:
epublish
Résumé
The increasing risk of obesity and diabetes among other metabolic disorders are the consequence of shifts in dietary patterns with high caloric-content food intake. We previously reported that megalin regulates energy homeostasis using blood-brain barrier (BBB) endothelial megalin-deficient (EMD) mice, since these animals developed obesity and metabolic syndrome upon normal chow diet administration. Obesity in mid-life appears to be related to greater dementia risk and represents an increasing global health issue. We demonstrated that EMD phenotype induced impaired learning ability and recognition memory, neurodegeneration, neuroinflammation, reduced neurogenesis, and mitochondrial deregulation associated with higher mitochondrial mass in cortical tissues. EMD mice were subjected to normal chow and high-fat diet (HFD) for 14 weeks and metabolic changes were evaluated. Surprisingly, BBB megalin deficiency protected against HFD-induced obesity improving glucose tolerance and preventing hepatic steatosis. Compared to wild type (wt), the brain cortex in EMD mice showed increased levels of the mitochondrial biogenesis regulator, peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α), and uncoupling protein 2 (UCP2), a thermogenic protein involved in the regulation of energy metabolism. This agreed with the previously found increased mitochondrial mass in the transgenic mice. Upon HFD challenge, we demonstrated these two proteins were found elevated in wt mice but reported no changes over the already increased levels in EMD animals. We propose a protective role for megalin on diet-induce obesity, suggesting this could be related to metabolic disturbances found in dementia through brain endocrine system communications.
Sections du résumé
BACKGROUND
BACKGROUND
The increasing risk of obesity and diabetes among other metabolic disorders are the consequence of shifts in dietary patterns with high caloric-content food intake. We previously reported that megalin regulates energy homeostasis using blood-brain barrier (BBB) endothelial megalin-deficient (EMD) mice, since these animals developed obesity and metabolic syndrome upon normal chow diet administration. Obesity in mid-life appears to be related to greater dementia risk and represents an increasing global health issue. We demonstrated that EMD phenotype induced impaired learning ability and recognition memory, neurodegeneration, neuroinflammation, reduced neurogenesis, and mitochondrial deregulation associated with higher mitochondrial mass in cortical tissues.
METHODS
METHODS
EMD mice were subjected to normal chow and high-fat diet (HFD) for 14 weeks and metabolic changes were evaluated.
RESULTS
RESULTS
Surprisingly, BBB megalin deficiency protected against HFD-induced obesity improving glucose tolerance and preventing hepatic steatosis. Compared to wild type (wt), the brain cortex in EMD mice showed increased levels of the mitochondrial biogenesis regulator, peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α), and uncoupling protein 2 (UCP2), a thermogenic protein involved in the regulation of energy metabolism. This agreed with the previously found increased mitochondrial mass in the transgenic mice. Upon HFD challenge, we demonstrated these two proteins were found elevated in wt mice but reported no changes over the already increased levels in EMD animals.
CONCLUSION
CONCLUSIONS
We propose a protective role for megalin on diet-induce obesity, suggesting this could be related to metabolic disturbances found in dementia through brain endocrine system communications.
Identifiants
pubmed: 31937343
doi: 10.1186/s12974-020-1702-2
pii: 10.1186/s12974-020-1702-2
pmc: PMC6961312
doi:
Substances chimiques
Low Density Lipoprotein Receptor-Related Protein-2
0
Lrp2 protein, mouse
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
22Subventions
Organisme : Instituto de Salud Carlos III
ID : PI15/00780
Organisme : Instituto de Salud Carlos III
ID : PI18/00118
Organisme : Instituto de Salud Carlos III
ID : PI2016/01
Organisme : Comunidad de Madrid
ID : NEUROMETAB-CM
Références
Br J Clin Pharmacol. 2013 Mar;75(3):738-55
pubmed: 23384081
Ann Med. 2005;37(5):347-56
pubmed: 16179270
Cell Metab. 2012 Dec 5;16(6):723-37
pubmed: 23217255
Neurobiol Aging. 2010 Sep;31(9):1516-31
pubmed: 18926603
Cell Metab. 2007 Jan;5(1):21-33
pubmed: 17189204
Arch Neurol. 2002 Aug;59(8):1258-63
pubmed: 12164721
N Engl J Med. 2004 Feb 12;350(7):664-71
pubmed: 14960743
Nat Commun. 2013;4:1862
pubmed: 23673647
Endocrinology. 2000 Nov;141(11):4226-38
pubmed: 11089557
J Neurol. 2004 Mar;251(3):314-20
pubmed: 15015012
Diabetes. 2014 Jun;63(6):1907-13
pubmed: 24520120
Obesity (Silver Spring). 2007 Apr;15(4):798-808
pubmed: 17426312
Neurobiol Aging. 2014 Jun;35(6):1233-42
pubmed: 24411482
J Cereb Blood Flow Metab. 2012 Jul;32(7):1362-76
pubmed: 22453628
Biol Psychiatry. 2011 Apr 1;69(7):668-74
pubmed: 21035790
J Clin Invest. 1997 Feb 1;99(3):385-90
pubmed: 9022070
Endocrinology. 2004 Nov;145(11):4880-9
pubmed: 15271881
Diabetologia. 2010 Sep;53(9):2008-19
pubmed: 20490453
Endocrinology. 2004 Aug;145(8):3935-40
pubmed: 15131016
Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G987-95
pubmed: 18772365
JAMA. 2008 Mar 12;299(10):1185-7
pubmed: 18334695
J Clin Invest. 2000 Aug;106(4):473-81
pubmed: 10953022
Nat Med. 1995 Nov;1(11):1155-61
pubmed: 7584987
Diabetologia. 2002 May;45(5):740-3
pubmed: 12107756
J Neuroinflammation. 2017 Jan 31;14(1):26
pubmed: 28143489
Acta Neuropathol. 2014 Jan;127(1):3-28
pubmed: 24096619
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5166-70
pubmed: 2839833
Int J Obes (Lond). 2009 Aug;33(8):893-8
pubmed: 19506566
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9635-40
pubmed: 22645355
Nat Rev Mol Cell Biol. 2002 Apr;3(4):256-66
pubmed: 11994745
Prev Med. 2014 Oct;67:199-203
pubmed: 25091878
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8738-43
pubmed: 23650363
Methods Enzymol. 1993;225:890-900
pubmed: 8231893
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7815-20
pubmed: 18509063
FASEB J. 2004 May;18(7):902-4
pubmed: 15033922
Neurobiol Aging. 2008 Jun;29(6):902-12
pubmed: 17324488
PLoS One. 2013 Oct 28;8(10):e78554
pubmed: 24205258
Cell Metab. 2019 Nov 5;30(5):952-962.e5
pubmed: 31495690
Ann Med. 2007;39(3):219-28
pubmed: 17457719
Endocrinology. 2010 Apr;151(4):1532-40
pubmed: 20176720
Ann Neurol. 1997 Nov;42(5):776-82
pubmed: 9392577
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8460-4
pubmed: 8710893
Annu Rev Nutr. 2001;21:407-28
pubmed: 11375443
Cell. 2016 Feb 25;164(5):872-83
pubmed: 26919426
Proc Nutr Soc. 2013 Feb;72(1):160-5
pubmed: 23110988
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 8;84(Pt A):294-303
pubmed: 29524513
Cell Metab. 2013 Nov 5;18(5):649-59
pubmed: 24120943
J Alzheimers Dis. 2014;39(4):711-7
pubmed: 24254699
Neuromolecular Med. 2007;9(4):324-30
pubmed: 17999206
Diabetes Technol Ther. 2011 Jan;13(1):19-25
pubmed: 21175267
Neuroscience. 2014 Sep 26;277:36-44
pubmed: 25003714
Dement Geriatr Cogn Disord. 2010;29(6):543-52
pubmed: 20606436
Endocrine. 2009 Oct;36(2):311-25
pubmed: 19669948
J Biol Chem. 2000 Apr 21;275(16):12003-8
pubmed: 10766831
Mitochondrion. 2016 Jan;26:43-57
pubmed: 26678157
Cell. 2006 Oct 20;127(2):397-408
pubmed: 17055439
Cell. 2007 Apr 20;129(2):251-62
pubmed: 17448988
Curr Alzheimer Res. 2008 Feb;5(1):15-25
pubmed: 18288927
PLoS One. 2009;4(4):e5370
pubmed: 19401758
Diabetes. 2006 Dec;55 Suppl 2:S9-S15
pubmed: 17130651
BMJ. 2005 Jun 11;330(7504):1360
pubmed: 15863436
Lancet. 2005 Dec 17;366(9503):2112-7
pubmed: 16360788
Arch Neurol. 2009 Mar;66(3):336-42
pubmed: 19273752
Ann N Y Acad Sci. 2002 Jun;967:379-88
pubmed: 12079865
J Biol Chem. 2012 Mar 2;287(10):7213-23
pubmed: 22232553
Obes Rev. 2011 May;12(5):e426-37
pubmed: 21348917
Diabetes. 2007 Aug;56(8):2085-92
pubmed: 17519422
Mol Metab. 2015 Jul 15;4(9):631-42
pubmed: 26413469